Rheumatoid Arthritis Response to Methotrexate
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Rheumatoid Arthritis
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Rheumatoid arthritis patients with active disease who start subcutaneous methotrexate by their rheumatologist prescription methotrexate will be included. Patients will participate in a prospective and observational study in which the response to methotrexate will be assessed by ultrasound (US) of jo...
Rheumatoid arthritis patients with active disease who start subcutaneous methotrexate by their rheumatologist prescription methotrexate will be included. Patients will participate in a prospective and observational study in which the response to methotrexate will be assessed by ultrasound (US) of joints and tendons. The main objective of the study is the change in B mode and Doppler mode US after 24 weeks of methotrexate treatment.
Tracking Information
- NCT #
- NCT03535519
- Collaborators
- Nordic Pharma SAS
- Investigators
- Principal Investigator: Juan Carlos Nieto González, PhD Hospital General Universitario Gregorio Maranon
Get Well Soon